RecruitingNot ApplicableNCT05502224

Multidisciplinary Approach to Fatigue

Pilot Project for the Implementation of an Integrated Multidisciplinary Follow-up for Young Patients With Breast Cancer or Germ Cell Tumor


Sponsor

Jules Bordet Institute

Enrollment

50 participants

Start Date

Aug 19, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Prospective longitudinal, single-center, non-randomized study for the implementation of an integrated multidisciplinary fatigue follow-up for young patients with breast cancer or germ cell tumour


Eligibility

Min Age: 18 YearsMax Age: 39 Years

Inclusion Criteria5

  • Age between 18 and 39 years at the time of signing the informed consent
  • Patient who speaks and understands French
  • Signed study informed consent form obtained prior to any study related procedures
  • At minimum, a moderate (\>3) fatigue level according to the Standard Rating Scale (NRS) 1 month after completion of acute treatment; as measured at the Survivorship of the standard program
  • Patient with either: curative breast cancer (AJCC stage I-II-III) or a germ cell tumor

Exclusion Criteria3

  • Refusal to participate in the study
  • Patient having chosen to participate in another psychosocial intervention study for the duration of the study.
  • Patients with AJCC stage IV breast cancer

Interventions

OTHERErgospirometry

Maximum aerobic capacity (VO2 max), Maximum load, Ventilatory threshold and the patient's RQ


Locations(1)

Institut Jules Bordet

Brussels, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05502224


Related Trials